Sanofi

News

Sanofi snaps up acne vaccine developer Origimm Bio

Sanofi has added to its vaccine pipeline with an agreement to acquire Austria's Origimm Biotechnology and its vaccine-based immunotherapy for people with acne.

News

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company.

News

AI specialist Owkin snares $270m alliance with Sanofi in onc...

Sanofi has made another investment in artificial intelligence, taking a $180 million equity stake in Franco-US startup Owkin with another $90 million in funding for a program to seek out ne

News

Merck's oral PCSK9 drug matches injectables in early trials

Injectable antibodies targeting PCSK9 have failed to take off as expected in the cholesterol-lowering market, but Merck & Co hopes to do much better with an oral alternative.

News

Sanofi winds $40m into UK gene therapy firm Gyroscope

French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapi

News

Dupixent scores a first in rare skin disease prurigo nodular...

Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitatin

Sanofi snaps up acne vaccine developer Origimm Bio

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

AI specialist Owkin snares $270m alliance with Sanofi in onc...

Merck's oral PCSK9 drug matches injectables in early trials

Sanofi winds $40m into UK gene therapy firm Gyroscope

Dupixent scores a first in rare skin disease prurigo nodular...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Sanofi

Editor's Picks